The 2024 revisions to the McDonald criteria increase the proportion of people who can be diagnosed with MS and allow for ...

The 41st ECTRIMS Congress kicks off in Barcelona, Spain, with a focus on advances in understanding and diagnosing MS.

The U.S. Food and Drug Administration is delaying by three months its decision on whether or not to approve tolebrutinib for ...

Fasting and ketogenic diets were found to benefit blood fats, weight, and blood pressure in MS, but did not reduce brain ...

A new version of the McDonald criteria — the official guidelines used to diagnose MS — aim to make MS diagnosis faster and ...

An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...

An analysis found that MS patients on a less frequent anti-CD20 therapy dosing schedule do not have more relapses or show ...

Children who go on to develop pediatric-onset MS have more emergency department visits than their peers, starting years ...

Paramagnetic rim lesions, or areas of damage in the brain and spinal cord, could be a useful tool for diagnosing MS, a study ...

The patent comes months after Immunic Therapeutics announced CALLIPER study results, which tested vidofludimus calcium in ...

As cold and flu season approaches, columnist Leigh Anne Nelson shares her experience getting vaccinated against the flu and ...

TG Therapeutics has started enrolling adults with relapsing forms of MS for a Phase 3 trial testing a subcutaneous ...